Author

Li C. Xia

South China University of Technology

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Genetic & Genomic Medicine· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Assay:whole-exome sequencing· 2 Assay:whole-genome sequencing· 2 Research Focus:cell type annotation· 1 Assay:DNA methylation· 1 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1

Frequent Co-Authors

Binyu YangiD· 1 shared Bozhen Ren· 1 shared Christina M. Wood-Bouwens· 1 shared Derrick S. Haslem· 1 shared Gail Fulde· 1 shared Hanlee P. JiiD· 1 shared HoJoon LeeiD· 1 shared Huiling LiuiD· 1 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Binyu YangORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Multi-trait genome-wide analysis identified novel risk loci and candidate drugs for heart failure

Zhengyang Yu, Maohuan Lin, Zhanyu Liang, Bozhen Ren, Ying Yang, Xiaoling Lin, Huiling Liu, Yangxin Chen, Kaida Ning, Li C. Xia

This study identifies novel genetic risk loci and potential drugs for heart failure using multi-trait genome-wide analysis of GWAS data.

Human Genetics and Genomics Advances · Oct 30, 2025Peer-reviewedGenetic & Genomic Medicine

Identifying gastric cancer molecular subtypes by integrating DNA-based hierarchical classification strategy and clinical stratification

Binyu Yang, Siying Liu, Jiemin Xie, Xi Tang, Pan Guan, Yifan Zhu, Li C. Xia

This study develops a DNA-based classifier for gastric cancer molecular subtyping, achieving high accuracy and improved clinical stratification.

bioRxiv · Jun 9, 2023 · PreprintBioinformatics

Whole genome analysis identifies the association of TP53 genomic deletions with lower survival in Stage III colorectal cancer

Li C. Xia, Paul Van Hummelen, Matthew A. Kubit, HoJoon Lee, John Bell, Susan M. Grimes, Christina M. Wood-Bouwens, Stephanie Greer, Tyler Barker, Derrick S. Haslem, James M. Ford, Gail Fulde, Hanlee P. Ji, Lincoln D. Nadauld

The paper identifies TP53 genomic deletions as a poor prognosis marker in Stage III colorectal cancer using a new low-coverage whole-genome sequencing protocol.

Scientific Reports · Mar 19, 2020Peer-reviewedGenomics